Stay Notified Of Our Blog Updates

Announcing our partnership with Serosep Ltd.

Thomas Beuls | Press Release | UgenTec | Partnership | 19/04/2018

We're excited to announce today our partnership with Serosep Ltd.,  a leading global manufacturer of molecular solutions for clinical laboratories. In the partnership, we will add the Serosep EntericBio assay range to our platform FastFinder. 

Announcing the Molecular Automation Network & our partnership with Hamilton Robotics

Thomas Beuls | Press Release | UgenTec | Partnership | 10/04/2018

We're excited to announce our brand new initiative in molecular diagnostics: the Molecular Automation Network. This network is a consortium of companies that are currently active in molecular diagnostics & automation. Its purpose is to connect the MDx industry better, enabling more complete solutions and end to end workflows across the globe.

Announcing our $ 9.3 million Series A funding

Thomas Beuls | Funding | Press Release | UgenTec | 29/03/2018

We're excited to announce our series A funding round. Existing and new investors subscribed to the round for a total worth of $9,3 million (€7,5 million). The funds will be used to consolidate our leading position in clinical diagnostics, setting up a US office and expanding to new markets.

UgenTec and MDxHealth sign partnership agreement for software to support interpretation of molecular test results

Thomas Beuls | Press Release | Partnership | 23/01/2018

HERSTAL & HASSELT, BELGIUM – 23/01/18 | UgenTec, an innovative European medical device software company that develops artificially intelligent PCR interpretation software, announced today a partnership agreement with MDxHealth, a multinational healthcare company that uses molecular diagnostics to personalize urological cancer diagnosis and treatment.

UgenTec expands management team and appoints Steven Verhoeven as CEO

Thomas Beuls | Press Release | UgenTec | 19/12/2017

Hasselt, Belgium, December 19, 2017. | Steven Verhoeven, previously Agilent’s head of genomics software, will join UgenTec to take up the role of chief executive officer, the current role of founder Wouter Uten. Verhoeven will be responsible for continuing the exponential growth of UgenTec, exploring new markets & maintaining investor relations.